US Stock MarketDetailed Quotes

LGND Ligand Pharmaceuticals

Watchlist
  • 108.550
  • +2.790+2.64%
Close Apr 24 16:00 ET
  • 108.550
  • 0.0000.00%
Post 20:01 ET
2.09BMarket Cap-493.41P/E (TTM)

Ligand Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
95.75%97.05M
253.02%28.47M
377.77%36.53M
16,336.59%13.31M
-44.82%18.73M
-64.04%49.58M
-84.92%8.07M
-62.68%7.65M
-100.69%-82K
-34.73%33.95M
Net income from continuing operations
-107.73%-4.03M
-270.93%-31.09M
30.19%-7.17M
-2,366.86%-51.91M
105.34%86.14M
256.33%52.15M
204.02%18.19M
-2,642.82%-10.27M
355.87%2.29M
372.66%41.95M
Operating gains losses
15.17%-40.54M
355.12%36.84M
2.66%10.45M
620.82%20.79M
-174.75%-108.62M
-45.26%-47.79M
67.48%-14.44M
17,759.65%10.18M
-3,570.43%-3.99M
-448.46%-39.53M
Depreciation and amortization
-3.51%35.24M
-3.24%8.63M
4.45%8.99M
-6.76%8.85M
-7.73%8.77M
-29.13%36.52M
-21.08%8.92M
-36.24%8.61M
-27.45%9.5M
-30.38%9.5M
Deferred tax
-235.09%-15.8M
-357.18%-12.69M
-124.83%-1.99M
-106.66%-20.67M
123.28%19.55M
-43.56%11.7M
-89.34%4.94M
163.32%8.01M
-407.22%-10M
154.10%8.75M
Other non cash items
10.90%6.7M
-83.33%718K
509.81%7.53M
27.53%982K
-844.57%-2.52M
2.93%6.04M
103.06%4.31M
-19.29%1.23M
-49.38%770K
-138.09%-267K
Change In working capital
156.26%19.36M
172.55%11.6M
134.18%7.12M
-38.97%-7.61M
4.38%8.24M
-152.38%-34.4M
-160.18%-15.99M
-515.73%-20.83M
62.74%-5.48M
-83.81%7.9M
-Change in receivables
-148.33%-6.46M
-299.82%-5.67M
160.58%4.79M
-757.15%-9.05M
215.01%3.46M
-104.70%-2.6M
-91.85%2.84M
-197.67%-7.91M
106.74%1.38M
-97.48%1.1M
-Change in inventory
188.49%9.62M
262.94%2.57M
416.20%1.93M
119.14%2.49M
29.34%2.63M
-190.15%-10.87M
-47.86%707K
-163.51%-611K
-234.09%-13M
4,525.00%2.04M
-Change in payables and accrued expense
395.56%13.9M
309.36%11.29M
189.04%2.23M
139.16%1.77M
-217.70%-1.38M
-40.84%-4.7M
193.94%2.76M
-163.28%-2.5M
-174.41%-4.53M
83.94%-435K
-Change in other working capital
114.13%2.29M
115.32%3.42M
81.33%-1.83M
-126.44%-2.82M
-32.07%3.53M
-1,089.45%-16.23M
-235.95%-22.29M
-453.82%-9.81M
561.24%10.67M
-33.50%5.2M
Cash from discontinued investing activities
Operating cash flow
95.75%97.05M
253.02%28.47M
377.77%36.53M
16,336.59%13.31M
-44.82%18.73M
-64.04%49.58M
-84.92%8.07M
-62.68%7.65M
-100.69%-82K
-34.73%33.95M
Investing cash flow
Cash flow from continuing investing activities
-1,129.79%-143.66M
-275.56%-38.62M
-138.46%-46.51M
-824.71%-54.76M
-135.79%-3.78M
-107.14%-11.68M
-41.19%-10.28M
-201.71%-19.5M
-80.04%7.56M
-90.74%10.55M
Net PPE purchase and sale
48.28%-1.82M
-70.74%-712K
-22.38%-596K
-100.99%-408K
95.65%-105K
80.35%-3.52M
80.43%-417K
88.75%-487K
96.92%-203K
50.48%-2.41M
Net intangibles purchase and sale
79.18%-10.39M
105.05%2.54M
-9,629.41%-12.96M
543.37%534K
-485.38%-501K
-54,350.00%-49.91M
-4,877.47%-50.26M
114.17%136K
--83K
--130K
Net business purchase and sale
-571.20%-172.19M
--0
-275.16%-96.19M
---75M
---998K
-3,320.53%-25.65M
---14K
---25.64M
--0
--0
Net investment purchase and sale
-35.85%43.24M
-200.10%-40.45M
874.74%63.24M
194.62%22.62M
-116.92%-2.17M
-63.20%67.4M
882.30%40.41M
-73.43%6.49M
-82.71%7.68M
-89.26%12.83M
Net other investing changes
---2.5M
--0
--0
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-1,129.79%-143.66M
-275.56%-38.62M
-138.46%-46.51M
-824.71%-54.76M
-135.79%-3.78M
-107.14%-11.68M
-41.19%-10.28M
-201.71%-19.5M
-80.04%7.56M
-90.74%10.55M
Financing cash flow
Cash flow from continuing financing activities
262.04%97.14M
283.59%20.39M
1,584.40%55.08M
114.01%9.49M
1,671.87%12.18M
78.28%-59.95M
200.32%5.32M
108.01%3.27M
-13.99%-67.76M
99.55%-775K
Net issuance payments of debt
99.97%-25K
-20.00%-6K
28.57%-10K
99.99%-4K
61.54%-5K
70.54%-76.9M
90.74%-5K
99.96%-14K
-28.25%-76.87M
99.99%-13K
Net common stock issuance
--37.14M
--3.11M
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
192.18%65.59M
196.31%19.34M
531.68%21.4M
4.48%9.55M
351.05%15.3M
594.55%22.45M
365.81%6.53M
313.05%3.39M
1,276.81%9.14M
877.81%3.39M
Net other financing activities
-1.20%-5.56M
-70.23%-2.05M
-225.24%-335K
-78.13%-57K
24.98%-3.12M
69.83%-5.5M
81.85%-1.21M
97.43%-103K
81.40%-32K
43.84%-4.16M
Cash from discontinued financing activities
Financing cash flow
262.04%97.14M
283.59%20.39M
1,584.40%55.08M
114.01%9.49M
1,671.87%12.18M
78.28%-59.95M
200.32%5.32M
108.01%3.27M
-13.99%-67.76M
99.55%-775K
Net cash flow
Beginning cash position
-49.00%22.95M
220.37%63.62M
-36.23%18.14M
-43.54%50.09M
-49.00%22.95M
130.54%45.01M
382.46%19.86M
438.73%28.45M
491.80%88.73M
130.54%45.01M
Current changes in cash
329.11%50.52M
230.62%10.24M
625.25%45.1M
46.99%-31.95M
-37.93%27.14M
-186.53%-22.05M
-92.43%3.1M
-637.71%-8.59M
-520.64%-60.28M
1,065.38%43.72M
Effect of exchange rate changes
---1.17M
---1.55M
----
----
----
--0
--0
----
----
----
End cash Position
215.01%72.31M
215.01%72.31M
220.37%63.62M
-36.23%18.14M
-43.54%50.09M
-49.00%22.95M
-49.00%22.95M
382.46%19.86M
438.73%28.45M
491.80%88.73M
Free cash flow
1,911.96%77.41M
165.04%27.76M
211.34%22.29M
4,021.05%11.18M
-48.68%16.18M
-103.56%-4.27M
-181.60%-42.68M
-52.90%7.16M
-105.39%-285K
-33.10%31.53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 95.75%97.05M253.02%28.47M377.77%36.53M16,336.59%13.31M-44.82%18.73M-64.04%49.58M-84.92%8.07M-62.68%7.65M-100.69%-82K-34.73%33.95M
Net income from continuing operations -107.73%-4.03M-270.93%-31.09M30.19%-7.17M-2,366.86%-51.91M105.34%86.14M256.33%52.15M204.02%18.19M-2,642.82%-10.27M355.87%2.29M372.66%41.95M
Operating gains losses 15.17%-40.54M355.12%36.84M2.66%10.45M620.82%20.79M-174.75%-108.62M-45.26%-47.79M67.48%-14.44M17,759.65%10.18M-3,570.43%-3.99M-448.46%-39.53M
Depreciation and amortization -3.51%35.24M-3.24%8.63M4.45%8.99M-6.76%8.85M-7.73%8.77M-29.13%36.52M-21.08%8.92M-36.24%8.61M-27.45%9.5M-30.38%9.5M
Deferred tax -235.09%-15.8M-357.18%-12.69M-124.83%-1.99M-106.66%-20.67M123.28%19.55M-43.56%11.7M-89.34%4.94M163.32%8.01M-407.22%-10M154.10%8.75M
Other non cash items 10.90%6.7M-83.33%718K509.81%7.53M27.53%982K-844.57%-2.52M2.93%6.04M103.06%4.31M-19.29%1.23M-49.38%770K-138.09%-267K
Change In working capital 156.26%19.36M172.55%11.6M134.18%7.12M-38.97%-7.61M4.38%8.24M-152.38%-34.4M-160.18%-15.99M-515.73%-20.83M62.74%-5.48M-83.81%7.9M
-Change in receivables -148.33%-6.46M-299.82%-5.67M160.58%4.79M-757.15%-9.05M215.01%3.46M-104.70%-2.6M-91.85%2.84M-197.67%-7.91M106.74%1.38M-97.48%1.1M
-Change in inventory 188.49%9.62M262.94%2.57M416.20%1.93M119.14%2.49M29.34%2.63M-190.15%-10.87M-47.86%707K-163.51%-611K-234.09%-13M4,525.00%2.04M
-Change in payables and accrued expense 395.56%13.9M309.36%11.29M189.04%2.23M139.16%1.77M-217.70%-1.38M-40.84%-4.7M193.94%2.76M-163.28%-2.5M-174.41%-4.53M83.94%-435K
-Change in other working capital 114.13%2.29M115.32%3.42M81.33%-1.83M-126.44%-2.82M-32.07%3.53M-1,089.45%-16.23M-235.95%-22.29M-453.82%-9.81M561.24%10.67M-33.50%5.2M
Cash from discontinued investing activities
Operating cash flow 95.75%97.05M253.02%28.47M377.77%36.53M16,336.59%13.31M-44.82%18.73M-64.04%49.58M-84.92%8.07M-62.68%7.65M-100.69%-82K-34.73%33.95M
Investing cash flow
Cash flow from continuing investing activities -1,129.79%-143.66M-275.56%-38.62M-138.46%-46.51M-824.71%-54.76M-135.79%-3.78M-107.14%-11.68M-41.19%-10.28M-201.71%-19.5M-80.04%7.56M-90.74%10.55M
Net PPE purchase and sale 48.28%-1.82M-70.74%-712K-22.38%-596K-100.99%-408K95.65%-105K80.35%-3.52M80.43%-417K88.75%-487K96.92%-203K50.48%-2.41M
Net intangibles purchase and sale 79.18%-10.39M105.05%2.54M-9,629.41%-12.96M543.37%534K-485.38%-501K-54,350.00%-49.91M-4,877.47%-50.26M114.17%136K--83K--130K
Net business purchase and sale -571.20%-172.19M--0-275.16%-96.19M---75M---998K-3,320.53%-25.65M---14K---25.64M--0--0
Net investment purchase and sale -35.85%43.24M-200.10%-40.45M874.74%63.24M194.62%22.62M-116.92%-2.17M-63.20%67.4M882.30%40.41M-73.43%6.49M-82.71%7.68M-89.26%12.83M
Net other investing changes ---2.5M--0--0----------------------------
Cash from discontinued investing activities
Investing cash flow -1,129.79%-143.66M-275.56%-38.62M-138.46%-46.51M-824.71%-54.76M-135.79%-3.78M-107.14%-11.68M-41.19%-10.28M-201.71%-19.5M-80.04%7.56M-90.74%10.55M
Financing cash flow
Cash flow from continuing financing activities 262.04%97.14M283.59%20.39M1,584.40%55.08M114.01%9.49M1,671.87%12.18M78.28%-59.95M200.32%5.32M108.01%3.27M-13.99%-67.76M99.55%-775K
Net issuance payments of debt 99.97%-25K-20.00%-6K28.57%-10K99.99%-4K61.54%-5K70.54%-76.9M90.74%-5K99.96%-14K-28.25%-76.87M99.99%-13K
Net common stock issuance --37.14M--3.11M--------------0--0------------
Proceeds from stock option exercised by employees 192.18%65.59M196.31%19.34M531.68%21.4M4.48%9.55M351.05%15.3M594.55%22.45M365.81%6.53M313.05%3.39M1,276.81%9.14M877.81%3.39M
Net other financing activities -1.20%-5.56M-70.23%-2.05M-225.24%-335K-78.13%-57K24.98%-3.12M69.83%-5.5M81.85%-1.21M97.43%-103K81.40%-32K43.84%-4.16M
Cash from discontinued financing activities
Financing cash flow 262.04%97.14M283.59%20.39M1,584.40%55.08M114.01%9.49M1,671.87%12.18M78.28%-59.95M200.32%5.32M108.01%3.27M-13.99%-67.76M99.55%-775K
Net cash flow
Beginning cash position -49.00%22.95M220.37%63.62M-36.23%18.14M-43.54%50.09M-49.00%22.95M130.54%45.01M382.46%19.86M438.73%28.45M491.80%88.73M130.54%45.01M
Current changes in cash 329.11%50.52M230.62%10.24M625.25%45.1M46.99%-31.95M-37.93%27.14M-186.53%-22.05M-92.43%3.1M-637.71%-8.59M-520.64%-60.28M1,065.38%43.72M
Effect of exchange rate changes ---1.17M---1.55M--------------0--0------------
End cash Position 215.01%72.31M215.01%72.31M220.37%63.62M-36.23%18.14M-43.54%50.09M-49.00%22.95M-49.00%22.95M382.46%19.86M438.73%28.45M491.80%88.73M
Free cash flow 1,911.96%77.41M165.04%27.76M211.34%22.29M4,021.05%11.18M-48.68%16.18M-103.56%-4.27M-181.60%-42.68M-52.90%7.16M-105.39%-285K-33.10%31.53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.